NCT07173036View on ClinicalTrials.gov

Evaluation of (Cardio)Metabolic and Auxological Outcomes of GHD Patients Under rhGH or LAGH With Stratification According to IGF-1 Levels

NANot yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

September 1, 2031

Conditions
Growth Hormone Deficiency
Interventions
OTHER

metabolic and auxological outcomes

Evaluation over a three-year period following the initiation of treatment with daily recombinant human growth hormone (rhGH)

OTHER

metabolic and auxological outcomes

Evaluation over a three-year period following the initiation of treatment with weekly long-acting growth hormone (LAGH).

All Listed Sponsors
lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

NCT07173036 - Evaluation of (Cardio)Metabolic and Auxological Outcomes of GHD Patients Under rhGH or LAGH With Stratification According to IGF-1 Levels | Biotech Hunter | Biotech Hunter